Hereditary renal cancer syndromes: An update of a systematic review

European Urology

Volumn 58, Issue 5, 2010, Pages 701-710

  Verine, Jérôme ^a,b,c   Pluvinage, Amélie ^a,c   Bousquet, Guilhem ^a,b   Lehmann Che, Jacqueline ^a,b,c   De Bazelaire, Cédric ^a,c   Soufir, Nadem ^b,c,d   Mongiat Artus, Pierre ^a,b,c  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

Birt Hogg Dub syndrome; Constitutional chromosome 3 translocations; Genetic counselling; Hereditary cancer; Hereditary leiomyomatosis renal cell carcinoma; Hereditary papillary renal cell carcinoma; Kidney cancer; Renal cell carcinoma

Indexed keywords

GENE PRODUCT;

AUTOSOMAL DOMINANT INHERITANCE; BIRT HOGG DUBE SYNDROME; CHROMOSOME TRANSLOCATION 3; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; CRYOTHERAPY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FAMILIAL CANCER; FOLLOW UP; GENETIC COUNSELING; HEREDITARY LEIOMYOMATOSIS RENAL CELL CARCINOMA; HEREDITARY PAPILLARY RENAL CELL CARCINOMA; HEREDITARY RENAL CANCER SYNDROME; HISTOLOGY; HUMAN; JAW TUMOR; KIDNEY CANCER; KIDNEY FUNCTION; LEIOMYOMA; LEIOMYOSARCOMA; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SKIN TUMOR; SYNDROME; SYNDROME DELINEATION; SYSTEMATIC REVIEW; THYROID PAPILLARY CARCINOMA; TUBEROUS SCLEROSIS; UTERUS MYOMA; VON HIPPEL LINDAU DISEASE;

BIRT-HOGG-DUBE SYNDROME; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; TUBEROUS SCLEROSIS; VON HIPPEL-LINDAU DISEASE;

EID: 77957588953     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.08.031     Document Type: Review

References (65)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. D. Pascual, and A. Borque Epidemiology of kidney cancer Adv Urol 2008 782 831
3. B.I. Rini, S.C. Campbell, and B. Escudier Renal cell carcinoma Lancet 373 2009 1119 1132
4. C.P. Pavlovich, and L.S. Schmidt Searching for the hereditary causes of renal-cell carcinoma Nature Rev 4 2004 381 393
5. E.C. Pfaffenroth, and W.M. Linehan Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy Expert Opin Biol Ther 8 2008 779 790
6. J.A. Coleman Familial and hereditary renal cancer syndromes Urol Clin North Am 35 2008 563 572 v. Review
7. S. Richard, R. Lidereau, and S. Giraud The growing family of hereditary renal cell carcinoma Nephrol Dial Transplant 19 2004 2954 2958
8. W.M. Linehan, P.A. Pinto, and G. Bratslavsky Hereditary kidney cancer: Unique opportunity for disease-based therapy Cancer 115 2009 2252 2261
9. R.R. Lonser, G.M. Glenn, and M. Walther Von Hippel-Lindau disease Lancet 361 2003 2059 2067
10. W.G. Kaelin Von Hippel-Lindau disease Ann Rev Pathol 2 2007 145 173
11. S.C. Clifford, and E.R. Maher Von Hippel-Lindau disease: Clinical and molecular perspectives Adv Cancer Res 82 2001 85 105
12. M.M. Walther, P.L. Choyke, and G. Weiss Parenchymal sparing surgery in patients with hereditary renal cell carcinoma J Urol 153 1995 913 916
13. M. Meister, P. Choyke, C. Anderson, and U. Patel Radiological evaluation, management, and surveillance of renal masses in von Hippel-Lindau disease Clin Radiol 64 2009 589 600
14. C. Stolle, G. Glenn, and B. Zbar Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene Hum Mutat 12 1998 417 423
15. S.J. Mandriota, K.J. Turner, and D.R. Davies HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron Cancer Cell 1 2002 459 468
16. W.M. Linehan, G. Bratslavsky, and P.A. Pinto Molecular diagnosis and therapy of kidney cancer Ann Rev Med 61 2010 329 343
17. L.S. Schmidt, M.L. Nickerson, and D. Angeloni Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene J Urol 172 2004 1256 1261
18. I. Rosner, G. Bratslavsky, P.A. Pinto, and W.M. Linehan The clinical implications of the genetics of renal cell carcinoma Urol Oncol 27 2009 131 136
19. D. Cohen, and M. Zhou Molecular genetics of familial renal cell carcinoma syndromes Clin Lab Med 25 2005 259 277
20. P.L. Choyke, G.M. Glenn, and M.M. Walther Hereditary renal cancers Radiology 226 2003 33 46
21. L. Schmidt, K. Junker, and N. Nakaigawa Novel mutations of the met proto-oncogene in papillary renal carcinomas Oncogene 18 1999 2343 2350
22. W.M. Linehan, P.A. Pinto, and R. Srinivasan Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics Clin Cancer Res 13 2007 671s 679s
23. V. Launonen, O. Vierimaa, and M. Kiuru Inherited susceptibility to uterine leiomyomas and renal cell cancer Proc Natl Acad Sci USA 98 2001 3387 3392
24. N.A. Alam, E. Barclay, and A.J. Rowan Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome Arch Dermatol 141 2005 199 206
25. M. Kiuru, V. Launonen, and M. Hietala Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology Am J Pathol 159 2001 825 829
26. T.A. Koski, H.J. Lehtonen, and K.J. Jee Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer Genes Chromosomes Cancer 48 2009 544 551
27. J.R. Toro, M.L. Nickerson, and M.H. Wei Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America Am J Hum Genet 73 2003 95 106
28. M.J. Merino, C. Torres-Cabala, P. Pinto, and W.M. Linehan The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome Am J Surg Pathol 31 2007 1578 1585
29. R.L. Grubb 3rd, M.E. Franks, and J. Toro Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer J Urol 177 2007 2074 2079 discussion 2079-80
30. H.J. Lehtonen, M. Kiuru, and S.K. Ylisaukko-Oja Increased risk of cancer in patients with fumarate hydratase germline mutation J Med Genet 43 2006 523 526 (Pubitemid 43927328)
31. S. Badeloe, and J. Frank Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis Eur J Dermatol 19 2009 545 551
32. M.H. Wei, O. Toure, and G.M. Glenn Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer J Med Genet 43 2006 18 27
33. J.S. Isaacs, Y.J. Jung, and D.R. Mole HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability Cancer Cell 8 2005 143 153
34. G. Bratslavsky, S. Sudarshan, L. Neckers, and W.M. Linehan Pseudohypoxic pathways in renal cell carcinoma Clin Cancer Res 13 2007 4667 4671
35. O. Yogev, O. Yogev, and E. Singer Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response PLoS Biol 8 2010 e1000328
36. N.A. Alam, A.J. Rowan, and N.C. Wortham Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency Hum Mol Genet 12 2003 1241 1252
37. F.H. Menko, M.A. van Steensel, and S. Giraud Birt-Hogg-Dubé syndrome: diagnosis and management Lancet Oncol 10 2009 1199 1206
38. J.R. Toro, M.H. Wei, and G.M. Glenn BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports J Med Genet 45 2008 321 331
39. I. Kluijt, D. de Jong, and H.J. Teertstra Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome Clin Genet 75 2009 537 543
40. C.P. Pavlovich, M.M. Walther, and R.A. Eyler Renal tumors in the Birt-Hogg-Dubé syndrome Am J Surg Pathol 26 2002 1542 1552
41. C.P. Pavlovich, R.L. Grubb 3rd, and K. Hurley Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome J Urol 173 2005 1482 1486
42. N. Kluger, S. Giraud, and I. Coupier Birt-Hogg-Dubé syndrome: clinical and genetic studies of 10 French families Br J Dermatol 162 2010 527 537
43. J.R. Toro, S.E. Pautler, and L. Stewart Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome Am J Respir Crit Care Med 175 2007 1044 1053
44. M.S. Nahorski, D.H. Lim, and L. Martin Investigation of the Birt-Hogg-Dubé tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer J Med Genet 47 2010 385 390
45. T.R. Hartman, E. Nicolas, and A. Klein-Szanto The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis Oncogene 28 2009 1594 1604
46. T. Rosser, A. Panigrahy, and W. McClintock The diverse clinical manifestations of tuberous sclerosis complex: a review Semin Pediatr Neurol 13 2006 27 36
47. P.B. Crino, K.L. Nathanson, and E.P. Henske The tuberous sclerosis complex N Engl J Med 355 2006 1345 1356
48. A.K. Leung, and W.L. Robson Tuberous sclerosis complex: a review J Pediatr Health Care 21 2007 108 114
49. C.J. Haven, F.K. Wong, and E.W. van Dam A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome J Clin Endocrinol Metab 85 2000 1449 1454
50. P.J. Newey, M.R. Bowl, and R.V. Thakker Parafibromin - functional insights J Intern Med 266 2009 84 98
51. L. Lin, J.H. Zhang, L.M. Panicker, and W.F. Simonds The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene Proc Natl Acad Sci USA 105 2008 17420 17425
52. C.D. Malchoff, M. Sarfarazi, and B. Tendler Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome J Clin Endocrinol Metab 85 2000 1758 1764
53. C. Ricketts, E.R. Woodward, and P. Killick Germline SDHB mutations and familial renal cell carcinoma J Natl Cancer Inst 100 2008 1260 1262
54. S. Vanharanta, M. Buchta, and S.R. McWhinney Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma Am J Hum Genet 74 2004 153 159
55. A. Henderson, F. Douglas, and P. Perros SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis Fam Cancer 8 2009 257 260
56. M.R. Morris, E. Maina, and N.V. Morgan Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma J Clin Pathol 57 2004 706 711
57. E.R. Woodward, A.B. Skytte, D.G. Cruger, and E.R. Maher Population-based survey of cancer risks in chromosome 3 translocation carriers Genes Chromosomes Cancer 49 2010 52 58
58. R.P. Kuiper, L. Vreede, and R. Venkatachalam The tumor suppressor gene fbxw7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer Cancer Genet Cytogenet 195 2009 105 111
59. B. Zbar Inherited epithelial tumors of the kidney: old and new diseases Semin Cancer Biol 10 2000 313 318
60. E.R. Woodward, C. Ricketts, and P. Killick Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN Clin Cancer Res 14 2008 5925 5930
61. H.T. Cohen, and F.J. McGovern Renal-cell carcinoma N Engl J Med 353 2005 2477 2490
62. P.L. Choyke Imaging of hereditary renal cancer Radiol Clin North Am 41 2003 1037 1051
63. M.L. Poulsen, E. Budtz-Jorgensen, and M.L. Bisgaard Surveillance in von Hippel-Lindau disease (VHL) Clin Genet 77 2010 49 59
64. G.N. Gupta, J. Peterson, and K.N. Thakore Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm J Urol 184 2010 59 63
65. A.B. Reed, and D.J. Parekh Surgical management of von Hippel-Lindau disease: urologic considerations Surg Oncol Clin North Am 18 2009 157 174 x. Review